Skip to main content
. 2023 Nov 29;330(23):2267–2274. doi: 10.1001/jama.2023.24391

Table 1. Characteristics of the Patients at Baseline in the NICO Trial.

Characteristic No. (%)
Restricted intubation (n = 116) Control (n = 109)
Sex
Female 46 (39.7) 39 (35.8)
Male 70 (60.3) 70 (64.2)
Age, median (IQR), y 33 (25-49) 34 (26-49)
Site of inclusion
Emergency department 73 (62.9) 66 (60.6)
Prehospital 43 (37.1) 42 (38.5)
Intensive care unit 0 1 (0.9)
Heart rate, bpm 85 (18) [n = 114] 85 (20) [n = 107]
Heart rate >100 24 (21.1) 20 (18.7)
Blood pressure, mm Hg n = 115 n = 106
Systolic, mean (SD) 113.6 (14.8) 117.9 (18.9)
Systolic ≤100 21 (18.3) 18 (17.0)
Diastolic, mean (SD) 70.3 (13.3) 70.6 (14.2) [n = 107]
Respiratory rate, mean (SD), breaths per min 17.2 (4.3) [n = 73] 16.8 (4.4) [n = 72]
Respiratory rate ≤12 13 (17.8) 10 (13.9)
Peripheral oxygen saturation, median (IQR), % 97 (95-99) [n = 114] 97(95-100) [n = 107]
Peripheral oxygen saturation <95% 17 (14.9) 17 (15.9)
Median Glasgow Coma Scale score, median (IQR) 6 (3-7) 6 (3-7)
Glasgow coma scale score = 3 38 (33) 28 (23)
Estimated body mass indexa 25 (5) [n = 98] 24 (4) [n = 102]
Toxinb
Alcohol 79 (68.1) 71 (65.1)
Benzodiazepines 45 (38.8) 44 (40.4)
Neuroleptic 25 (19.0) 31 (28.4)
GHB/GBL 14 (12.1) 11 (10.1)
Crack/cocaine 13 (11.2) 6 (5.5)
Opioid/heroine 11 (9.5) 13 (11.9)
Amphetamines 9 (7.8) 11 (10.1)
Cannabinoid 9 (7.8) 6 (5.5)
Selective serotonin reuptake inhibitor 6 (5.2) 9 (8.3)
Tricyclic antidepressant 6 (5.2) 9 (8.3)
Paracetamol 5 (4.3) 4 (3.7)
Other 9 (7.8) 11 (10.1)
Intubation 19 (16.4) 63 (57.8)

Abbreviations: bpm, beats per minute; GHB, γ-hydroxybutyric acid; GBL, γ-butyrolactone; NICO, Non-invasive Airway Management of Comatose Poisoned Emergency Patients.

a

Calculated as weight in kilograms divided by height in meters squared.

b

Toxins involved were either suspected, reported by the patient or a relative, or proven by biological analysis. The sum of percentages exceeds 100% because several toxins may be involved.